The World Health Organization (WHO) has recognized obesity as one of the top ten threats
to human health. It is estimated that the number of obese and overweight people worldwide …

Diabetes mellitus is a metabolic disease characterized by long-term hyperglycaemia, which
leads to microangiopathy and macroangiopathy and ultimately increases the mortality of …

The metabolic syndrome comprises a cluster of cardiometabolic risk factors, with insulin
resistance and adiposity as its central features. Identifying individuals with metabolic …

Adipose tissue is acknowledged as an endocrine organ that releases bioactive factors
termed adipokines. Visfatin was initially identified as a novel adipokine with insulin‐mimetic …

Abstract Visfatin/extracellular-nicotinamide-phosphoribosyltranferase-(eNampt) is a
multifaceted adipokine enhanced in type-2-diabetes and obesity. Visfatin/eNampt cause in …

Methods This case-control study was conducted in a tertiary care hospital in Pakistan from
January 2020 to April 2020. Ninety-two participants with BMI greater than 25 kg/m 2, with no …

Resistin is an adipocyte-and monocyte-derived cytokine which has been implicated in the
modulation of insulin action, energy, glucose and lipid homeostasis. Resistin has been …

Musculoskeletal pathologies (MSPs) such as osteoarthritis (OA) and osteoporosis (OP), are
a set of disorders that cause severe pain, motion difficulties, and even permanent disability …

Background There is little data on the metabolic effects of adipokines in sub-Saharan African
populations. This study aimed to explore the potential relationship of leptin and adiponectin …

Adipose tissue is an endocrine organ that produces molecules with important functions in
the human body called adipokines. Visfatin can be secreted from various sources, such as …